Results 101 to 110 of about 191,841 (164)

[Autism spectrum disorder today: critical reflections on hyperdiagnosis]. [PDF]

Cad Saude Publica
Silva RAD, Queiroz SDPO, Silva FPD.
europepmc   +1 more source

Estimation of care costs for individuals with cystic fibrosis at a referral center: cohort study, Salvador, 2005-2022. [PDF]

Epidemiol Serv Saude
Costa JCB, Sorte NCAB, D'Souza EL.
europepmc   +1 more source

Expert participation in the health technology assessment process: a scoping review. [PDF]

Rev Bras Enferm
Figueiredo SMDS, Costa FNA, Nascimento MHM, Paula CC, Machado LB, Fonseca ERD, Teixeira E.   +6 more
europepmc   +1 more source

[Arthroplasty in Thumb (CMC Joint) Osteoarthritis: Avoiding Trapeziectomy]. [PDF]

Rev Bras Ortop (Sao Paulo)
Aita MA, Aita GC, Rocha C, Savaris S, Leite M, Cabanilla SP.   +5 more
europepmc   +1 more source

Value-Based Healthcare in Cardiology: How to Integrate a more Comprehensive View into Medical Decision-Making? [PDF]

Arq Bras Cardiol
Silva PGMBE, Furlan V, Lopes RD, Volschan A, Souza PCP, Polanczyk CA.   +5 more
europepmc   +1 more source

Challenges in Performing Real-World Evidence Studies in Low-Middle Income Countries: the EdoBRA Study. [PDF]

Arq Bras Cardiol
Massaro AR.
europepmc   +1 more source

[Twenty years since the publication of medication price regulation in Brazil: time to update?] [PDF]

Cad Saude Publica
Melo VA, Santana RS, Galato D.
europepmc   +1 more source

Artificial Intelligence computed tomography models for the discrimination of Wilms versus non-Wilms tumors: systematic review and meta-analysis. [PDF]

J Bras Nefrol
Feitosa Filho HN, Lima RV, Furtado JFCU, Ohannesian VA, Eulálio EC, Ribeiro PVC, Paiva LMA, Feitosa ID, Silva Júnior GBD.   +8 more
europepmc   +1 more source

Anti-PLA2R antibodies: implications for therapeutic planning and the prediction of remission in membranous nephropathy. [PDF]

J Bras Nefrol
Mastroianni-Kirsztajn G, Riguetti MTP, Siliano JM.   +2 more
europepmc   +1 more source

Real-world cost-effectiveness analysis of thymoglobulin versus no induction therapy in kidney transplant recipients at low risk of graft loss. [PDF]

J Bras Nefrol
Bessa AB, Cristelli MP, Felipe CR, Foresto RD, Fonseca MCM, Pestana JM, Tedesco-Silva H.   +6 more
europepmc   +1 more source